266 results on '"Colhoun H."'
Search Results
2. The misclassification of facial expressions in generalised social phobia
3. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland
4. Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study
5. Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001–2007
6. The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1
7. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
8. Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?
9. Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000–2007)
10. Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes
11. Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
12. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland
13. The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes
14. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland
15. A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
16. Do men develop type 2 diabetes at lower body mass indices than women?
17. Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
18. A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain
19. The use of metformin in type 1 diabetes: a systematic review of efficacy
20. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme
21. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
22. Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)
23. A genetic link between type 2 diabetes and prostate cancer
24. Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)
25. Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database
26. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999
27. Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)
28. Investigation of known estimated glomerular filtration rate loci in patients with Type 2 diabetes
29. Trends in hypertension management in Type I diabetes across Europe, 1989/1990 – 1997/1999
30. Risk factors for renal failure: The WHO multinational study of vascular disease in diabetes
31. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
32. Nitric oxide and vascular responses in Type I diabetes
33. Evidence for lipotoxicity? Both measured and genetically determined lipid levels are associated with rate of deterioration of Type 2 diabetes: A5 (P88)
34. Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study
35. What are the effects of metformin in Type 1 diabetes? A systematic review: SD14 (P418)
36. SHOULD TRIGLYCERIDE BE TARGETED TO REDUCE CVD RISK?
37. Relative risk of mortality associated with diabetes in Scotland in 2007: a nationwide record linkage study: SD20 (P275)
38. Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects
39. Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS)
40. Neuropsychological function in social phobia
41. Mortality in people with Type 2 diabetes in the UK
42. The effect of Atorvastatin therapy on C-reactive protein in patients with Type 2 Diabetes Mellitus and no prior history of cardiovascular disease, in the Collaborative Atorvastatin Diabetes Study (CARDS): A96
43. Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes
44. The incidence of stroke in Type 1 diabetic patients directly compared with a nondiabetic population from the General Practice Research Database, 1992–99
45. All-cause mortality rates in Type 1 diabetic patients compared with a nondiabetic population from the General Practice Research Database, 1992–99
46. Hypertension management in primary prevention Type 2 diabetic patients in the Collaborative Atorvastatin Diabetes Study (CARDS)
47. Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes
48. vWF activity, endothelial nitric oxide production and atherosclerosis in type 1 diabetes
49. Risk stratification for diabetic eye screening. Reply to Stratton I. M. and Aldington S. J. [letter]
50. Blood lead concentrations in United Kingdom have fallen substantially since 1984
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.